Risk factors for ethambutol-induced optic neuropathy: a systematic review and meta-analysis of comparative studies
Authors:
- Arnav GuptaAGArnav Gupta
- Tushar TejpalTTTushar Tejpal
- Aswen SriranganathanASAswen Sriranganathan
- Benson ChenBCBenson Chen
- Matthew P. QuinnMQMatthew P. Quinn
- Edsel B. IngEIEdsel B. Ing
- Rahul A. SharmaRSRahul A. Sharma
- 16 April 2026
- journal article
- review article
- Published by Elsevier in Canadian Journal of Ophthalmology
- Vol. 61 (4) , 908-917
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- Pregnane X Receptor Activator Rifampin Increases Blood Pressure and Stimulates Plasma Renin ActivityClinical Pharmacology & Therapeutics, 2020
- Ethambutol-induced optic neuropathy in renal disorder: a clinico-electrophysiological studyCanadian Journal of Ophthalmology, 2019
- Ethambutol toxicity exacerbating the phenotype of CMT2A2Muscle & Nerve, 2013
- Ethambutol-induced optic neuropathy linked to OPA1 mutation and mitochondrial toxicityMitochondrion, 2010
- Risk factors for ethambutol optic toxicityInternational Ophthalmology, 2009
- Leber's Hereditary Optic Neuropathy Precipitated by EthambutolJapanese Journal of Ophthalmology, 2006
- Leber's hereditary optic neuropathy mutations in ethambutol-induced optic neuropathyJournal of Neurology, 2003
- Ethambutol-Induced Vacuolar Changes and Neuronal Loss in Rat Retinal Cell Culture: Mediation by Endogenous ZincToxicology and Applied Pharmacology, 2000
- A case of ethambutol-induced optic neuropathy harbouring the primary mitochondrial LHON mutation at nt 11778.Journal of Neurology, 1998
- Rifampicin and NephrotoxicityArchives of internal medicine (1960), 1988